Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and etomidate volume ratios for cognitive recovery after painless gastroenteroscopy in elderly patients
ChiCTR2400083329Phase 4Not yet recruiting
- Sponsor
- Yibin Second People's Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol and etomidate in None and perioperative neurocognitive disorder (5 arms), sponsored by Yibin Second People's Hospital. Primary endpoint: Incidence of cognitive dysfunction. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
propofoletomidate
03
Conditions
perioperative neurocognitive disorder
Beyond the preview
Go deeper on ChiCTR2400083329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083329.